- Report
- January 2022
- 40 Pages
Russia
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
South Korea
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
United States
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €1432EUR$1,500USD£1,199GBP
- Report
- July 2024
- 38 Pages
Spain
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 38 Pages
Russia
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 36 Pages
Mexico
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 36 Pages
Japan
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 36 Pages
Brazil
From €4767EUR$4,995USD£3,994GBP
- Report
- July 2024
- 38 Pages
China
From €4767EUR$4,995USD£3,994GBP
- Report
- June 2023
- 132 Pages
Global
From €907EUR$950USD£760GBP
- Report
- December 2024
- 250 Pages
Global
From €2534EUR$2,655USD£2,123GBP
- Report
- April 2022
- 115 Pages
Global
From €3402EUR$3,565USD£2,851GBP
The Thrombectomy Device market is a subset of the Cardiovascular Devices market. It is composed of medical devices used to remove blood clots from the body, typically from the arteries. These devices are used to treat a variety of conditions, including stroke, deep vein thrombosis, and pulmonary embolism. Thrombectomy devices are typically minimally invasive, and can be used in both open and endovascular procedures.
The Thrombectomy Device market is highly competitive, with a variety of companies offering a range of products. Some of the major players in the market include Medtronic, Boston Scientific, Johnson & Johnson, Stryker, and Terumo. Other companies in the market include Merit Medical, Penumbra, and Teleflex. Show Less Read more
